William Monteiro

6.9k total citations · 1 hit paper
20 papers, 2.7k citations indexed

About

William Monteiro is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, William Monteiro has authored 20 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 17 papers in Pulmonary and Respiratory Medicine and 5 papers in Infectious Diseases. Recurrent topics in William Monteiro's work include Asthma and respiratory diseases (18 papers), Respiratory and Cough-Related Research (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). William Monteiro is often cited by papers focused on Asthma and respiratory diseases (18 papers), Respiratory and Cough-Related Research (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). William Monteiro collaborates with scholars based in United Kingdom, New Zealand and United States. William Monteiro's co-authors include Ian Pavord, Christopher E. Brightling, Andrew J. Wardlaw, Beverley Hargadon, Peter Bradding, Ruth H. Green, Sumit Gupta, Richard P. Marshall, Ana R. Sousa and Pranabashis Haldar and has published in prestigious journals such as New England Journal of Medicine, The Lancet and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

William Monteiro

20 papers receiving 2.6k citations

Hit Papers

Mepolizumab and Exacerbations of Refractory Eosinophilic ... 2009 2026 2014 2020 2009 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Monteiro United Kingdom 13 2.4k 1.9k 496 381 357 20 2.7k
Alberto Pesci Italy 21 1.2k 0.5× 2.0k 1.0× 315 0.6× 205 0.5× 163 0.5× 51 2.6k
M. Solèr Switzerland 16 1.1k 0.5× 1.2k 0.6× 175 0.4× 578 1.5× 153 0.4× 33 1.8k
H. Fox United Kingdom 8 1.8k 0.8× 1.4k 0.7× 262 0.5× 1.0k 2.7× 129 0.4× 37 2.1k
Hayley L. Parker United Kingdom 6 855 0.4× 425 0.2× 677 1.4× 127 0.3× 61 0.2× 8 1.4k
John B. Hagan United States 19 393 0.2× 338 0.2× 533 1.1× 492 1.3× 213 0.6× 56 1.4k
Oliviero Rossi Italy 18 460 0.2× 175 0.1× 322 0.6× 434 1.1× 97 0.3× 60 1.1k
Yotaro Takaku Japan 16 370 0.2× 452 0.2× 98 0.2× 67 0.2× 60 0.2× 58 814
Masayuki Hojo Japan 15 279 0.1× 306 0.2× 154 0.3× 104 0.3× 78 0.2× 103 840
Alejandro Teper Argentina 16 404 0.2× 634 0.3× 177 0.4× 45 0.1× 209 0.6× 64 1.0k
Thomas C. Kotsimbos Australia 11 449 0.2× 543 0.3× 93 0.2× 98 0.3× 195 0.5× 12 926

Countries citing papers authored by William Monteiro

Since Specialization
Citations

This map shows the geographic impact of William Monteiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Monteiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Monteiro more than expected).

Fields of papers citing papers by William Monteiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Monteiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Monteiro. The network helps show where William Monteiro may publish in the future.

Co-authorship network of co-authors of William Monteiro

This figure shows the co-authorship network connecting the top 25 collaborators of William Monteiro. A scholar is included among the top collaborators of William Monteiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Monteiro. William Monteiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woolnough, Kerry, William Monteiro, Michelle Craner, et al.. (2024). Identification of allergens from Aspergillus fumigatus—Potential association with lung damage in asthma. Allergy. 79(5). 1208–1218. 2 indexed citations
2.
May, Richard, Michael A. Ghebre, Laura Rapley, et al.. (2021). Sputum biomarkers during acute severe asthma attacks in children—a case‐control study. Acta Paediatrica. 111(3). 620–627. 2 indexed citations
3.
Holden, Karl, Andrew J. Wardlaw, Jack Satchwell, et al.. (2020). Fungal sensitization and positive fungal culture from sputum in children with asthma are associated with reduced lung function and acute asthma attacks respectively. Clinical & Experimental Allergy. 51(6). 790–800. 25 indexed citations
4.
Woolnough, Kerry, Paul J. Seear, Abbie Fairs, et al.. (2020). The airway fungal microbiome in asthma. Clinical & Experimental Allergy. 50(12). 1325–1341. 38 indexed citations
5.
Monteiro, William, et al.. (2019). Processing small sputum samples: a method validation study. Journal of Asthma. 57(2). 136–139. 3 indexed citations
6.
Beardsmore, Caroline, et al.. (2013). P87 Is fraction of exhaled nitric oxide (FeNO) in asymptomatic older teenagers related to preschool wheeze and chronic cough?. Thorax. 68(Suppl 3). A114.2–A114. 1 indexed citations
7.
Desai, Dhananjay, Sumit Gupta, Salman Siddiqui, et al.. (2013). Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma. Respiratory Research. 14(1). 17–17. 19 indexed citations
8.
Gupta, Sumit, Ruth Hartley, Umair Khan, et al.. (2013). Quantitative computed tomography–derived clusters: Redefining airway remodeling in asthmatic patients. Journal of Allergy and Clinical Immunology. 133(3). 729–738.e18. 95 indexed citations
9.
Agbetile, Joshua, Abbie Fairs, Dhananjay Desai, et al.. (2012). Isolation of filamentous fungi from sputum in asthma is associated with reduced post‐bronchodilator FEV1. Clinical & Experimental Allergy. 42(5). 782–791. 71 indexed citations
10.
Fairs, Abbie, Joshua Agbetile, Michelle Bourne, et al.. (2012). Isolation ofAspergillus fumigatusfrom sputum is associated with elevated airborne levels in homes of patients with asthma. Indoor Air. 23(4). 275–284. 24 indexed citations
11.
Fairs, Abbie, Joshua Agbetile, Beverley Hargadon, et al.. (2010). IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma. American Journal of Respiratory and Critical Care Medicine. 182(11). 1362–1368. 196 indexed citations
12.
Yousaf, Nadia, William Monteiro, Debbie Parker, et al.. (2010). Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial. Thorax. 65(12). 1107–1110. 45 indexed citations
13.
Agbetile, Joshua, Abbie Fairs, Michelle Bourne, et al.. (2010). S136 Fungal sputum culture in patients with severe asthma is associated with a reduced post bronchodilator FEV1. Thorax. 65(Suppl 4). A61–A62. 1 indexed citations
14.
Bafadhel, Mona, Amisha Singapuri, Sarah Terry, et al.. (2010). Body Mass and Fat Mass in Refractory Asthma: An Observational 1 Year Follow-Up Study. PubMed. 2010. 1–9. 12 indexed citations
15.
Siddiqui, Salman, Glenn Cruse, Susan McKenna, et al.. (2009). IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis. BMC Pulmonary Medicine. 9(1). 34–34. 17 indexed citations
16.
Bafadhel, Mona, Roshan Siva, Michael McCormick, et al.. (2009). Sputum IL-5 Concentration Is Associated with a Sputum Eosinophilia and Attenuated by Corticosteroid Therapy in COPD. Respiration. 78(3). 256–262. 42 indexed citations
17.
Haldar, Pranabashis, Christopher E. Brightling, Beverley Hargadon, et al.. (2009). Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma. New England Journal of Medicine. 360(10). 973–984. 1361 indexed citations breakdown →
18.
Haldar, Pranabashis, Christopher E. Brightling, Beverley Hargadon, et al.. (2009). Mepolizumab (Anti-IL5) and Exacerbation Frequency in Refractory Eosinophilic Asthma.. A3638–A3638. 3 indexed citations
19.
Siva, Roshan, Christopher E. Brightling, M. Shelley, et al.. (2007). Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. European Respiratory Journal. 29(5). 906–913. 343 indexed citations
20.
Brightling, Christopher E., William Monteiro, Richard J. Ward, et al.. (2000). Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. The Lancet. 356(9240). 1480–1485. 419 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026